#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.

POST Online Media Lite Edition



 

AngioDynamics bolsters senior leadership team with key appointments

Staff writer |
Albany, N.Y., USA - September 28, 2012, Albany, N.Y., USA - AngioDynamics, a provider of minimally invasive medical devices, announced the appointment of Louis J. Mazzarese, SVP and chief regulatory officer, effective October 3, 2012, and John Soto, SVP, global franchise, peripheral vascular, effective immediately.



Mr. Mazzarese brings more than 40 years of medical device and pharmaceutical experience, including driving strategic planning and professional development within the industry through his consulting practice.

Mr. Mazzarese's previous experience includes serving as Chief Regulatory Officer and Vice President, Corporate Regulatory Affairs for Edwards Lifesciences; Vice President of Regulatory and Clinical Affairs at Tyco Healthcare; and Vice President of Quality and Regulatory/Clinical Affairs at U.S. Surgical. Earlier in his career, he gained management experience at Pfizer-Shiley, Squibb Corporation, Ciba-Giegy, American McGaw and International Pharmaceutical Products.

Additionally, Mr. Mazzarese, who has a B.S. and M.S. in chemistry from Wagner College in Staten Island, N.Y., is past President and Chairman of the Regulatory Affairs Professional Society and a co-founder of the Association of Disposable Device Manufacturers.

Mr. Soto has an expansive background spanning from sales and marketing to international markets and regulatory environments, as well as finance and operations. Most recently he was Senior Vice President of Smith & Nephew's Global Hip Franchise. Mr. Soto is the former Senior Vice President of Global Sales for AngioDynamics — a role that he took on after the Company's acquisition of RITA Medical Systems in 2007, where he had served as Executive Vice President of Global Sales and Vice President of International Operations.

LATEST 5 MOVES FROM New York 


What to read next

AngioDynamics adds Kevin J. Gould to the board
AngioDynamics appoints James C. Clemmer as CEO
Eamonn Hobbs president & CEO of Delcath Systems